FDA Inspection 920664 — Eurofins Biopharma Product Testing Sweden AB
The FDA completed an inspection of Eurofins Biopharma Product Testing Sweden AB on Mar 9, 2015 in Uppsala. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 9, 2015
- Fiscal Year
- 2015
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Uppsala (Sweden)